Source: Annual Congress 2003 - Asthma and rhinitis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Wantke, W. Hemmer, M. Focke, M. Götz, R. Jarisch (Vienne, Austria). Diamine oxidase activation by diphenhydramine – in vitro but no in vivo effect. Eur Respir J 2003; 22: Suppl. 45, 758

Member's Comments

No comment yet.

Related content which might interest you: In vitro and in vivo modulation of NADPH oxidase activity and reactive oxygen species production in human neutrophils by a1-antitrypsin Source: ERJ Open Res, 7 (4) 00234-2021; 10.1183/23120541.00234-2021 Year: 2021 Absence of inhibitory effect of levocetirizine on the metabolism of human cytochrome P450 model substrates Source: Eur Respir J 2005; 26: Suppl. 49, 136s Year: 2005 Hypoxia-dependent regulation of non-phagocytic NADPH oxidase NOX4 in the pulmonary vasculature Source: Eur Respir J 2007; 30: Suppl. 51, 56s Year: 2007 Effect of nitric oxide synthase inhibition on airway smooth muscle contraction in mice deficient of the NADPH oxidase subunit p47phox Source: Eur Respir J 2005; 26: Suppl. 49, 224s Year: 2005 Combined inhibition of NADPH oxidase and inducible NOS in prevention of ischemia/reperfusion injury of the lung Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007 Effect of NAPDH oxidase inhibitors on lung fibroblast proliferation in systemic sclerosis Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 The effect of Monoamine oxidase A inhibition on experimentally induced pulmonary arterial hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 The novel phosphodiesterase 4 inhibitor CI-1044 inhibits in vitro LPS-induced TNFα production in whole blood of COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 34s Year: 2001 Novel inhibitory effect on 5-lipoxygenase activity by montelukast. Evidence for a noncompetitive mode of action Source: Eur Respir J 2004; 24: Suppl. 48, 96s Year: 2004 Xanthine oxidase inhibitors reduce rhinovirus induced IL-8 and GRO-α production in bronchial epithelial cells Source: Eur Respir J 2007; 30: Suppl. 51, 721s Year: 2007 Anti-oxidative and anti-inflammatory effects of Xanthorrhizol on aeroallergens-induced biological responses in vitro and ex vivo Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 Role of NADPH oxidases Source: Lung Science Conference 2006 - Hypoxia in Lung Biology and Disease Year: 2006 In vitro and in vivo anti-inflammatory activity of the novel PDE4 inhibitor roflumilast Source: Eur Respir J 2001; 18: Suppl. 33, 35s Year: 2001 Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways Source: Eur Respir J 2004; 23: 496 Year: 2004 Role of the JAK/STAT pathway in activation of the xanthine dehydrogenase/oxidase in lung microvascular endothelial cells exposure to hypoxia Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007 Effects of inducible nitric oxide synthase and xanthine oxidase inhibitors on SEB-induced interstitial pneumonia in mice Source: Eur Respir J 2002; 19: 447-457 Year: 2002 In vitro and in vivo characterisation of the novel neutrophil elastase inhibitor BI 1323495 Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Effects of zileuton on leukotriene formation in human blood cells and expression of enzymes in the biosynthetic pathway Source: Eur Respir J 2006; 28: Suppl. 50, 316s Year: 2006 Comparison of inhibitory potentials of pranlukast and zafirlukast on human liver CYP isoforms Source: Eur Respir J 2003; 22: Suppl. 45, 102s Year: 2003 IL-13 enhances GSNO reductase activity and decreases intracellular S-nitrosothiols in lung epithelial cells Source: Eur Respir J 2006; 28: Suppl. 50, 103s Year: 2006